Live Analyst Rating Changes 3274 upgrades, downgrades & price-target moves · freshest Wall Street data, updated daily View live feed →
Analyst Tracker/Lyanne Harrison
BofA
Lyanne Harrison
Wall Street Analyst
★★☆☆☆
#1897
on 13Foresight · ranked by our own returns
0%
Success Rate
-27.1%
Average Return
0 of 3 calls profitable · -37.0% vs benchmark
📈 Across the calls we could measure, roughly 0% of Lyanne Harrison's ratings turned a profit when each position was held for 1 year — averaging -27.1% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

5 Buy 0 Hold 0 Sell
Lyanne's Stock Coverage 4 ratings · 2026-06-28
Company Date Position Consensus Price Target 1-Yr Return
RMD
Resmed
Jun 04, 2026 BUY Buy
+18.8% avg upside
27 analysts
$320.00
59.81% Upside
-2.9%
AU:ACL
Australian Clinical Labs Ltd
Jun 23, 2025 BUY Hold
+29.1% avg upside
6 analysts
$3.60
62.17% Upside
·
RCEL
Avita Medical
Aug 09, 2024 BUY Strong Buy
+157.3% avg upside
10 analysts
-55.6%
AU:SIG
Sigma Healthcare Ltd
Jun 07, 2023 HOLD Strong Buy
+131.5% avg upside
10 analysts
$0.85
69.32% Downside
·
Lyanne Harrison — Frequently Asked Questions
How accurate are Lyanne Harrison's stock ratings?
Based on the calls 13Foresight could measure, about 0% of Lyanne's ratings were profitable over a one-year hold, with an average return of -27.1% per rating, or -37.0% versus the S&P 500. We score every analyst the same way, from historical prices.
How is Lyanne ranked on 13Foresight?
Lyanne Harrison is currently ranked #1897 with a 2-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.
Which stocks does Lyanne cover?
Lyanne most recently has ratings on RMD, AU:ACL, RCEL, AU:SIG. See the full coverage table above for positions, price targets and our measured returns.
Where can I see other analyst ratings?
Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.